FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1500064345> ?p ?o ?g. }

• W1500064345 endingPage "424" @default.
• W1500064345 startingPage "412" @default.
• W1500064345 abstract "The pharmacologic profile of retigabine [RTG (international nonproprietary name); ezogabine, EZG (U.S. adopted name)], is different from all currently approved antiepileptic drugs (AEDs). Its primary mechanism of action (MoA) as a positive allosteric modulator of KCNQ2-5 (K(v) 7.2-7.5) ion channels defines RTG/EZG as the first neuronal potassium (K(+)) channel opener for the treatment of epilepsy. KCNQ2-5 channels are predominantly expressed in neurons and are important determinants of cellular excitability, as indicated by the occurrence of human genetic mutations in KCNQ channels that underlie inheritable disorders including, in the case of KCNQ2/3, the syndrome of benign familial neonatal convulsions. In vitro pharmacologic studies demonstrate that the most potent action of RTG/EZG is at KCNQ2-5 channels, particularly heteromeric KCNQ2/3. Furthermore, mutagenesis and modeling studies have pinpointed the RTG/EZG binding site to a hydrophobic pocket near the channel gate, indicating how RTG/EZG can stabilize the open form of KCNQ2-5 channels; the absence of this site in KCNQ1 also provides a clear explanation for the inbuilt selectivity RTG/EZG has for potassium channels other than the KCNQ cardiac channel. KCNQ channels are active at the normal cell resting membrane potential (RMP) and contribute a continual hyperpolarizing influence that stabilizes cellular excitability. The MoA of RTG/EZG increases the number of KCNQ channels that are open at rest and also primes the cell to retort with a larger, more rapid, and more prolonged response to membrane depolarization or increased neuronal excitability. In this way, RTG/EZG amplifies this natural inhibitory force in the brain, acting like a brake to prevent the high levels of neuronal action potential burst firing (epileptiform activity) that may accompany sustained depolarizations associated with the initiation and propagation of seizures. This action to restore physiologic levels of neuronal activity is thought to underlie the efficacy of RTG/EZG as an anticonvulsant in a broad spectrum of preclinical seizure models and in placebo-controlled trials in patients with partial epilepsy. In this article, we consider the pharmacologic characteristics of RTG/EZG at the receptor, cellular, and network levels as a means of understanding the novel and efficacious MoA of this new AED as defined in both preclinical and clinical research." @default.
• W1500064345 created "2016-06-24" @default.
• W1500064345 creator A5037742036 @default.
• W1500064345 creator A5037876897 @default.
• W1500064345 creator A5041773724 @default.
• W1500064345 date "2012-01-05" @default.
• W1500064345 modified "2023-10-11" @default.
• W1500064345 title "The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy" @default.
• W1500064345 cites W1596694562 @default.
• W1500064345 cites W1736719008 @default.
• W1500064345 cites W1892342982 @default.
• W1500064345 cites W1920696238 @default.
• W1500064345 cites W1969680395 @default.
• W1500064345 cites W1974286622 @default.
• W1500064345 cites W1974809694 @default.
• W1500064345 cites W1982816693 @default.
• W1500064345 cites W1987357626 @default.
• W1500064345 cites W1990039788 @default.
• W1500064345 cites W1995384122 @default.
• W1500064345 cites W1995410958 @default.
• W1500064345 cites W1996501896 @default.
• W1500064345 cites W1998249204 @default.
• W1500064345 cites W1999099291 @default.
• W1500064345 cites W2004208126 @default.
• W1500064345 cites W2005134750 @default.
• W1500064345 cites W2006805797 @default.
• W1500064345 cites W2013844266 @default.
• W1500064345 cites W2033494215 @default.
• W1500064345 cites W2035175313 @default.
• W1500064345 cites W2039056598 @default.
• W1500064345 cites W2042515922 @default.
• W1500064345 cites W2055127006 @default.
• W1500064345 cites W2055395721 @default.
• W1500064345 cites W2055766784 @default.
• W1500064345 cites W2058346833 @default.
• W1500064345 cites W2059836016 @default.
• W1500064345 cites W2062463079 @default.
• W1500064345 cites W2065214055 @default.
• W1500064345 cites W2065880551 @default.
• W1500064345 cites W2068942851 @default.
• W1500064345 cites W2070032514 @default.
• W1500064345 cites W2070085226 @default.
• W1500064345 cites W2071032731 @default.
• W1500064345 cites W2071335594 @default.
• W1500064345 cites W2072002678 @default.
• W1500064345 cites W2102991990 @default.
• W1500064345 cites W2103156942 @default.
• W1500064345 cites W2109545010 @default.
• W1500064345 cites W2114685731 @default.
• W1500064345 cites W2121382073 @default.
• W1500064345 cites W2130648955 @default.
• W1500064345 cites W2134418949 @default.
• W1500064345 cites W2137007692 @default.
• W1500064345 cites W2137263523 @default.
• W1500064345 cites W2140894987 @default.
• W1500064345 cites W2142318256 @default.
• W1500064345 cites W2148662056 @default.
• W1500064345 cites W2159579442 @default.
• W1500064345 cites W2160977211 @default.
• W1500064345 cites W2165094762 @default.
• W1500064345 cites W2166707375 @default.
• W1500064345 cites W2168858520 @default.
• W1500064345 cites W4231241402 @default.
• W1500064345 cites W4252943298 @default.
• W1500064345 cites W4376848283 @default.
• W1500064345 doi "https://doi.org/10.1111/j.1528-1167.2011.03365.x" @default.
• W1500064345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22220513" @default.
• W1500064345 hasPublicationYear "2012" @default.
• W1500064345 type Work @default.
• W1500064345 sameAs 1500064345 @default.
• W1500064345 citedByCount "258" @default.
• W1500064345 countsByYear W15000643452012 @default.
• W1500064345 countsByYear W15000643452013 @default.
• W1500064345 countsByYear W15000643452014 @default.
• W1500064345 countsByYear W15000643452015 @default.
• W1500064345 countsByYear W15000643452016 @default.
• W1500064345 countsByYear W15000643452017 @default.
• W1500064345 countsByYear W15000643452018 @default.
• W1500064345 countsByYear W15000643452019 @default.
• W1500064345 countsByYear W15000643452020 @default.
• W1500064345 countsByYear W15000643452021 @default.
• W1500064345 countsByYear W15000643452022 @default.
• W1500064345 countsByYear W15000643452023 @default.
• W1500064345 crossrefType "journal-article" @default.
• W1500064345 hasAuthorship W1500064345A5037742036 @default.
• W1500064345 hasAuthorship W1500064345A5037876897 @default.
• W1500064345 hasAuthorship W1500064345A5041773724 @default.
• W1500064345 hasBestOaLocation W15000643451 @default.
• W1500064345 hasConcept C12554922 @default.
• W1500064345 hasConcept C158494493 @default.
• W1500064345 hasConcept C166342909 @default.
• W1500064345 hasConcept C169760540 @default.
• W1500064345 hasConcept C170493617 @default.
• W1500064345 hasConcept C181911157 @default.
• W1500064345 hasConcept C185592680 @default.
• W1500064345 hasConcept C202751555 @default.
• W1500064345 hasConcept C2776120743 @default.
• W1500064345 hasConcept C2777194220 @default.

• next